Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

Synergistic benefit of citicoline and NMDA antagonist shown in animal models of stroke

April 18, 1997

BASF describes new glutamate antagonists

April 18, 1997

Naropin introduced in Germany

April 18, 1997

Aricept launched in U.K.

April 18, 1997

Update on Neurogen's schizophrenia program

April 18, 1997

Pfizer characterizes new antipsychotic agent

April 17, 1997

Pfizer describes substance P antagonists

April 17, 1997

Excitatory amino acid antagonists from Novartis

April 17, 1997

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026